Results 271 to 280 of about 1,072,475 (388)
Cis-Active Determinants of Cardiac-Specific Expression in the Human Atrial Natriuretic Peptide Gene [PDF]
Jiangping Wu+4 more
openalex +1 more source
Discovering new hub genes of dilated cardiomyopathy
Abstract Aims Dilated cardiomyopathy (DCM) has a poor prognosis and exhibits a complex and diverse aetiology and genetic profile. The genes responsible for the pathogenesis of DCM have not been fully identified. The present study aimed to explore new hub genes of DCM by mining the human DCM databases and further by experimental validation.
Jun‐Yan Zhu+9 more
wiley +1 more source
Podocyte specific knockout of the natriuretic peptide clearance receptor is podocyte protective in focal segmental glomerulosclerosis. [PDF]
Wang L, Tang Y, Buckley AF, Spurney RF.
europepmc +1 more source
Abstract Aims Information about current use of finerenone in patients with heart failure (HF) finerenone in clinical practice is scarce, and its effectiveness in clinical practice in patients is scarce. We aim to assess both the baseline clinical profile and prognostic role of finerenone in patients with HF, irrespective of ejection fraction.
Gonzalo Luis Alonso Salinas+32 more
wiley +1 more source
Impact of preoperative brain natriuretic peptide level for predicting postoperative respiratory complications. [PDF]
Miura K+10 more
europepmc +1 more source
Detection of C-Type natriuretic peptide compared with brain and atrial natriuretic peptide transcripts in human heart by the polymerase chain reaction [PDF]
Gerbes, Alexander L., Nemer, M.
core +1 more source
Asymptomatic reduced left ventricular ejection fraction (LVEF) in the acute phase of myocardial infarction (AMI) was associated with up to 20% 1‐year mortality after discharge, substantially higher than in recent post‐MI trials. Symptoms of heart failure (HF) during the index hospitalization was associated with worse outcomes in patients with preserved
Jarle Jortveit+3 more
wiley +1 more source